Dapsone 6% / Niacinamide 4%
Product Images NDC 72934-1063

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Dapsone 6% / Niacinamide 4% (NDC 72934-1063). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sincerus Florida, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

G (1063 2 End)

Label side view of DAPSONE 6% / NIACINAMIDE 4% product by Sincerus Florida, LLC. The label includes usage directions advising to apply topically as directed by a physician, for external use only, and to wash hands after use. It also lists the manufacturer address in Pompano Beach, FL, and provides contact phone numbers and a QR code.*

FDA Label Image

F (1063 2 Front)

DAPSONE USP 6% / NIACINAMIDE USP 4% gel in a 30 gm white container label with the Sincerus Florida logo. The label indicates the product is a compounded drug made in the USA and shows the NDC 72934-1063-2.*

FDA Label Image

D (1063 2 Middle)

DAPSONE 6% / NIACINAMIDE 4% topical product label by Sincerus Florida, LLC showing active ingredients Dapsone USP 6% and Niacinamide USP 4%, along with inactive ingredients Butylated Hydroxytoluene NF (BHT) 0.1%, Propylene Glycol USP 5%, and Suspensisse Gel 84.9%. The label includes manufacturing and lot information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.